JOSEPH J JR GRANO
CIK 1304755 · CEO and Chairman · last filed 2026-07-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.53M
Companies
6
Total Filings
36
Lifetime Open-Market Net
-$130.3K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIRT | Director | 42,214 | $58.73 | $2.48M | $0 | 6 | 2026-07-06 |
| GNMX | Director | 102,683 | $29.72 | $3.05M | $28.9K | 5 | 2018-11-13 |
| root9B Holdings, Inc. (RTNB) Delisted | CEO and Chairman | — | — | — | $0 | 1 | 2017-01-27 |
| Aevi Genomic Medicine, LLC (MDGN) Delisted | Director | 74,164 | — | — | -$15.8K | 2 | 2016-12-12 |
| Aevi Genomic Medicine, LLC (MDGN.WS) Delisted | Director | 71,164 | — | — | $300.0K | 5 | 2015-10-08 |
| AMERITYRE CORP (AMTY) Delisted | 76,367 | — | — | -$443.4K | 5 | 2008-01-17 |
Recent Filings · Page 3 of 4
36 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-05-04 | — | Buy (P) | +55,000 | $95.7K | |
| 2015-05-01 | — | Buy (P) | +57,000 | $99.1K | |
| 2015-02-20 | Aevi Genomic Medicine, LLC (MDGN.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-02-11 | — | Other (J) | +457,220 | $0 | |
| 2014-12-02 | Aevi Genomic Medicine, LLC (MDGN.WS) Delisted | Buy (P) | +48,780 | $200.0K | EDGAR |
| 2014-10-22 | — | Buy (P) | +105,000 | $89.0K | |
| 2014-01-06 | Aevi Genomic Medicine, LLC (MDGN.WS) Delisted | Grant (A) | +7,000 | $0 | EDGAR |
| 2013-07-25 | — | Grant (A) | — | $0 | |
| 2013-04-16 | Aevi Genomic Medicine, LLC (MDGN.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-01-17 | AMERITYRE CORP (AMTY) Delisted | Sell (S) | −41,687 | -$59.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.